Cargando…

A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer

BRCA1 is a key mediator of DNA repair pathways and participates in the maintenance of the genomic integrity of cells. The control of DNA damage repair mechanisms by BRCA1 is of great interest since molecular defects in this pathway may reflect a predictive value in terms of a cell’s sensitivity to D...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ratanaphan, Adisorn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509617/ https://www.ncbi.nlm.nih.gov/pubmed/23203101 http://dx.doi.org/10.3390/ijms131114898

Ejemplares similares

Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1
por: Ratanaphan, Adisorn, et al.
Publicado: (2014)

Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine
por: Nhukeaw, Tidarat, et al.
Publicado: (2014)

In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein
por: Atipairin, Apichart, et al.
Publicado: (2011)

Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)]
por: Chakree, Korawan, et al.
Publicado: (2012)

Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib
por: Hongthong, Khwanjira, et al.
Publicado: (2021)

BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
por: Wang, Li, et al.
Publicado: (2014)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target
por: Raimundo, Liliana, et al.
Publicado: (2021)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer
por: Matta, Jaime, et al.
Publicado: (2016)

Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017)

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
por: Tung, Nadine, et al.
Publicado: (2010)

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
por: Timilsina, Santosh, et al.
Publicado: (2022)

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
por: Litwiniuk, Maria M, et al.
Publicado: (2008)

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
por: Shao, Wenlin, et al.
Publicado: (2004)

BRCA1 and Metastasis: Outcome of Defective DNA Repair
por: Krishnan, Rehna, et al.
Publicado: (2021)

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers
por: Vocka, Michal, et al.
Publicado: (2019)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression
por: Wang, Chuying, et al.
Publicado: (2018)

Is There a Role for Base Excision Repair in Estrogen/Estrogen Receptor-Driven Breast Cancers?
por: Abdel-Fatah, Tarek M.A., et al.
Publicado: (2014)

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor–targeted breast cancer therapy
por: Xiao, Tengfei, et al.
Publicado: (2018)

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
por: Tung, Nadine, et al.
Publicado: (2010)

Decreased BRCA1 Confers Tamoxifen Resistance in Breast Cancer Cells by Altering Estrogen Receptor-Coregulator Interactions
por: Wen, Jie, et al.
Publicado: (2008)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Putative Biomarkers and Targets of Estrogen Receptor Negative Human Breast Cancer
por: Sahab, Ziad J., et al.
Publicado: (2011)

Estrogen Receptor Signaling in Breast Cancer
por: Miziak, Paulina, et al.
Publicado: (2023)

Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers
por: Setton, Jeremy, et al.
Publicado: (2023)

Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?
por: Vogel, W, et al.
Publicado: (2007)

The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer
por: Voutsadakis, Ioannis A., et al.
Publicado: (2023)

New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines
por: Crowe, David L, et al.
Publicado: (2006)

Cytotoxic and targeted therapy for BRCA1/2-driven cancers
por: Imyanitov, Evgeny N.
Publicado: (2021)

Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers
por: Germani, Aldo, et al.
Publicado: (2020)

Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients
por: Espinel, Whitney, et al.
Publicado: (2022)

Pancreatic Cancer: BRCA Targeted Therapy and Beyond
por: Keane, Fergus, et al.
Publicado: (2023)

Estrogen Receptors in Human Breast Cancer
por: Skinner, Louis G.
Publicado: (1976)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

The potential influence of breast cancer estrogen receptors’ distribution on active DNA demethylation
por: Linowiecka, Kinga, et al.
Publicado: (2019)

Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
por: González-Mora, Andrea Magali, et al.
Publicado: (2021)

The role of estrogen receptor beta in breast cancer
por: Zhou, Yujing, et al.
Publicado: (2020)

Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?
por: Narod, S A
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4t1eqrfmgbgerm00v87ktg15qq